Rierink updates: three new research briefings (5 Nov 2026)

[Rierink]

Three new briefings are up in Rierink's "Research briefings" section. Each summarises what the published literature reports, both favourable and unfavourable findings. No protocols.

- Favorable and unfavorable findings on Semax: https://rierink.com/en/blog/favorable-and-unfavorable-findings-on-semax
- Favorable and unfavorable findings on Epithalon: https://rierink.com/en/blog/favorable-and-unfavorable-findings-on-epithalon
- Favorable and unfavorable findings on DSIP: https://rierink.com/en/blog/favorable-and-unfavorable-findings-on-dsip

All briefings: https://rierink.com/en/blog
Janoshik Testing Fund (vote on what gets tested next): https://rierink.com/en/blog/janoshik-testing-fund

Rierink, Porto, Portugal.
For laboratory research use only. Not for human or veterinary use.